This topic contains a solution. Click here to go to the answer

Author Question: In a recent article, Keith-Spiegel and Koocher (2205) suggest that some researchers may be taking ... (Read 65 times)

Starlight

  • Hero Member
  • *****
  • Posts: 567
In a recent article, Keith-Spiegel and Koocher (2205) suggest that some researchers may be taking ethical shortcuts because
 
  a. they perceive the IRB to be unfair.
  b. they are not aware that their research must be reviewed by an IRB.
  c. IRB reviews take too long.
  d. IRB reviews cost too much money.

Question 2

Which has the effect of reducing variance?
 
  a. random assignment
 b. matched assignment
 c. holding variables constant
  d. random selection



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

blakeserpa

  • Sr. Member
  • ****
  • Posts: 338
Answer to Question 1

A

Answer to Question 2

c




Starlight

  • Member
  • Posts: 567
Reply 2 on: Jun 19, 2018
Great answer, keep it coming :)


skipfourms123

  • Member
  • Posts: 343
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

One way to reduce acid reflux is to lose two or three pounds. Most people lose weight in the belly area first when they increase exercise, meaning that heartburn can be reduced quickly by this method.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

In ancient Rome, many of the richer people in the population had lead-induced gout. The reason for this is unclear. Lead poisoning has also been linked to madness.

Did you know?

A strange skin disease referred to as Morgellons has occurred in the southern United States and in California. Symptoms include slowly healing sores, joint pain, persistent fatigue, and a sensation of things crawling through the skin. Another symptom is strange-looking, threadlike extrusions coming out of the skin.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library